secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2024-10-23T23:59:59+00:00
Accession:  0001104659-24-110891
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio prices $37.3M public offering of 12M shares and pre-funded warrants at $2.25/share
--------------------------------------------------------------------------------

- Offering consists of 12M shares at $2.25/share and 5.8M pre-funded warrants at $2.2499 each, exercisable at $0.0001.
- Net proceeds expected ~$37.3M after underwriting discounts and expenses; use for general corporate purposes including sales, marketing, R&D.
- Underwriters have a 30-day option to purchase up to an additional 2.67M shares.
- Pre-funded warrants are immediately exercisable; exercise price $0.0001; beneficial ownership cap of 9.99% or 4.99% at holder's election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465924110891/0001104659-24-110891-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465924110891/tm2426723d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-110891

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer